Clinitech Laboratory (BOM:544220) EPS (Basic): ₹1.84 (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:544220 Clinitech Laboratory Ltd BOM:544220
38 GF Score
Price ₹37.00
! 6 Warning Signs
View Full Analysis

What is Clinitech Laboratory EPS (Basic)?

Clinitech Laboratory BOM:544220 -7.50% 38 EPS (Basic) is ₹1.84 as of Mar. 2026. GuruFocus rates BOM:544220 with a GF Score™ of 38/100. The stock has 6 warning signs investors should review.

Clinitech Laboratory's basic earnings per share (Basic EPS) for the six months ended in Mar. 2026 was ₹0.52. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹1.84.

Clinitech Laboratory's EPS (Diluted) for the six months ended in Mar. 2026 was ₹0.52. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹1.84.

Clinitech Laboratory's EPS without NRI for the six months ended in Mar. 2026 was ₹0.52. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 1.84.

During the past 12 months, Clinitech Laboratory's average EPS without NRIGrowth Rate was -3.70% per year. During the past 3 years, the average EPS without NRI Growth Rate was -12.80% per year. During the past 5 years, the average EPS without NRI Growth Rate was -2.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 6 years, Clinitech Laboratory's highest 3-Year average EPS without NRI Growth Rate was -2.40% per year. The lowest was -12.80% per year. And the median was -6.10% per year.

Clinitech Laboratory  (BOM:544220) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Clinitech Laboratory EPS (Basic) Related Terms

Clinitech Laboratory EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Clinitech Laboratory's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Clinitech Laboratory EPS (Basic) Chart

Clinitech Laboratory Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EPS (Basic)
Get a 7-Day Free Trial 2.25 2.69 1.63 1.90 1.83

Clinitech Laboratory Semi-Annual Data
Mar21 Mar22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only 1.33 0.17 0.83 1.32 0.52
BOM:544220
38GF Score
Clinitech Laboratory Ltd BOM:544220
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Clinitech Laboratory EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Clinitech Laboratory's Basic EPS for the fiscal year that ended in Mar. 2026 is calculated as

Basic EPS (A: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(4.148-0)/2.267
=1.83

Clinitech Laboratory's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(1.146-0)/2.204
=0.52

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹1.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of ₹1.84 mean?
Clinitech Laboratory (BOM:544220) has a EPS (Basic) of ₹1.84 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Clinitech Laboratory and its competitors.
Is Clinitech Laboratory's EPS (Basic) too high?
Clinitech Laboratory's current EPS (Basic) is ₹1.84. Overall, Clinitech Laboratory has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does Clinitech Laboratory's EPS (Basic) compare to TMO and DHR?
Clinitech Laboratory's EPS (Basic) of ₹1.84 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Medical Diagnostics & Research company?
A good EPS (Basic) depends on the Medical Diagnostics & Research industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Clinitech Laboratory and its competitors. Clinitech Laboratory's current EPS (Basic) is ₹1.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clinitech Laboratory stock overvalued right now?
Clinitech Laboratory (BOM:544220) has a current EPS (Basic) of ₹1.84. The current EPS (Basic) is ₹1.84. Clinitech Laboratory's overall GF Score™ is 38/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Clinitech Laboratory (BOM:544220), the current EPS (Basic) is ₹1.84 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Clinitech Laboratory Business Description

Address AL-1/545 and 546, Sector 16, Opposite Radhikabai Meghe Vidyalaya, Airoli, Navi Mumbai, MH, IND, 400708
Clinitech Laboratory Ltd is an Indian diagnostic and healthcare services provider company. It operates a network of diagnostic centers in Thane and Navi Mumbai and offers various medical tests across multiple specialties, including biochemistry, immunology, hematology, molecular biology, serology, microbiology, and histopathology. It serves individual patients as well as corporate clients, aiming to provide affordable and comprehensive diagnostic solutions.
38GF Score

Get the complete analysis for BOM:544220

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹37.00
Price